Chronic Post-Amputation Pain Management Market by Type, Treatment Type, End-Use

Description

List of Tables

[180 Pages Report] The Chronic Post-Amputation Pain Management Market size was estimated at USD 5.65 billion in 2023 and expected to reach USD 5.96 billion in 2024, at a CAGR 5.66% to reach USD 8.31 billion by 2030.

Chronic post-amputation pain refers to the ongoing pain that some individuals experience after having a limb or part of a limb amputated. This type of pain manifests in various forms, including phantom limb pain, where the person feels pain in the part of the limb that is no longer there, and residual limb pain, which is pain in the stump of the amputated limb. The arising discomfort can be moderate to severe and might affect the individual's quality of life, making it difficult to perform daily activities and potentially leading to emotional or psychological distress. Managing this pain requires a combination of medical treatments, physical therapy, and sometimes psychological counseling to address the physical and emotional effects of amputation. A rise in the number of amputations primarily due to diabetes, vascular diseases, and traumatic injuries contributes to a greater demand for effective post-amputation pain management solutions. Government policies supporting healthcare services and reimbursement frameworks in many regions cover treatments for chronic pain management, making treatments more accessible to patients and further propelling market expansion. However, environmental concerns associated with developing and disposing of medical products for managing chronic post-amputation pain hinder market growth. Neuromodulation techniques, such as spinal cord and peripheral nerve stimulation, help manage chronic post-amputation pain. The research and development in more sophisticated neuromodulation devices that are less invasive and more user-friendly offer significant opportunities for chronic post-amputation pain management market growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 5.65 billion
Estimated Year [2024]	USD 5.96 billion
Forecast Year [2030]	USD 8.31 billion
CAGR (%)	5.66%

Regional Insights

In the Americas, particularly in the United States and Canada, there is a strong focus on advanced medicinal treatments and technology-driven solutions for managing chronic post-amputation pain. In addition, there is a growing emphasis on using neuromodulation devices, which help modulate pain signals before they reach the brain, and prosthetic alignment and fitting services reduce the discomfort caused by poorly fitted prostheses. In the Asia-Pacific region, the chronic post-amputation pain management market for managing chronic post-amputation pain is evolving, driven by increasing healthcare expenditure, growing awareness about pain management solutions, and an improved healthcare infrastructure. Countries, including Japan and Australia, feature advanced medical facilities and readily adopt new technologies and treatments. In the EMEA region, particularly In Europe, the availability of advanced healthcare facilities and a strong regulatory framework support a comprehensive approach to post-amputation pain management. Middle Eastern countries, particularly Gulf states such as Saudi Arabia and the UAE, are rapidly improving their healthcare infrastructure and have increasing access to modern pain management therapies. In Africa, there is an increasing recognition of the need for better pain management strategies, leading to gradual improvements in healthcare offerings.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Chronic Post-Amputation Pain Management Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Rising awareness of pain management options and better healthcare infrastructure
- Increasing preference for pharmacological and non-pharmacological pain management therapies
- Supportive government policies and healthcare reimbursement

Market Restraints
- High cost of treatment options

Market Opportunities
- Ongoing advancements in neuromodulation technologies
- Need for patient-centric healthcare models emphasizing personalized treatment plans

Market Challenges
- Limited availability of specialized medical professionals and issues associated with medication side effects

Market Segmentation Analysis
- Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
- End-Use: Growing need for chronic post-amputation pain management in hospitals

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Chronic Post-Amputation Pain Management Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Chronic Post-Amputation Pain Management Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees

Trinity Capital Inc. committed a USD 25 million investment to Neuros Medical, Inc. This infusion of capital aims to advance Neuros Medical's innovative bioelectric technology, which is dedicated to reducing chronic pain for individuals who have undergone amputations, improving their quality of life. [Published On: 2023-10-31]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Chronic Post-Amputation Pain Management Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Chronic Post-Amputation Pain Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Arm Dynamics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, ATI Physical Therapy, B. Braun Melsungen AG, Einstein Healthcare Network, GlaxoSmithKline PLC, Memorial Healthcare System, Novartis AG, Pfizer Inc., Physiopedia, Propel Physiotherapy, Select Medical Corporation, Smart Solutions Rehab Group, Teva Pharmaceutical Industries Ltd., and The Rehabilitation Hospital of Montana.

Market Segmentation & Coverage

This research report categorizes the Chronic Post-Amputation Pain Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Neuroma Pain
- Phantom Limb Pain
- Stump Pain

Treatment Type
- Medication
- Neuromodulation Techniques
- Surgical Interventions
- Therapy
  - Mirror Therapy
  - Physical Therapy
  - Psychological Therapy
End-Use
- Home Care
- Hospitals
- Pain Clinics
- Rehabilitation Centers

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-99555D550529

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Rising awareness of pain management options and better healthcare infrastructure
  - 5.1.1.2. Increasing preference for pharmacological and non-pharmacological pain management therapies
  - 5.1.1.3. Supportive government policies and healthcare reimbursement
- 5.1.2. Restraints
  - 5.1.2.1. High cost of treatment options
- 5.1.3. Opportunities
  - 5.1.3.1. Ongoing advancements in neuromodulation technologies
  - 5.1.3.2. Need for patient-centric healthcare models emphasizing personalized treatment plans
- 5.1.4. Challenges
  - 5.1.4.1. Limited availability of specialized medical professionals and issues associated with medication side effects
5.2. Market Segmentation Analysis
- 5.2.1. Type: Increasing demand for phantom limb pain management to enhance quality of life by relieving pain
- 5.2.2. End-Use: Growing need for chronic post-amputation pain management in hospitals
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Chronic Post-Amputation Pain Management Market, by Type

6.1. Introduction
6.2. Neuroma Pain
6.3. Phantom Limb Pain
6.4. Stump Pain

7. Chronic Post-Amputation Pain Management Market, by Treatment Type

7.1. Introduction
7.2. Medication
7.3. Neuromodulation Techniques
7.4. Surgical Interventions
7.5. Therapy

8. Chronic Post-Amputation Pain Management Market, by End-Use

8.1. Introduction
8.2. Home Care
8.3. Hospitals
8.4. Pain Clinics
8.5. Rehabilitation Centers

9. Americas Chronic Post-Amputation Pain Management Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Chronic Post-Amputation Pain Management Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Chronic Post-Amputation Pain Management Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Trinity Capital Invested in Neuros Medical to Enhance Pain Management for Amputees
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio